Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

BTS 2014 Report: Protecting the allograft – preventing and treating chronic antibody-mediated rejection

Written by | 15 Apr 2014

Maria Dalby reporting from the annual British Transplantation Society meeting in Glasgow by Anthony Dorling, King’s College London – Chronic rejection is a major cause of graft failure… read more.

BTS 2014 Report: A case I wish I never did

Written by | 14 Apr 2014

Maria Dalby reporting on the presentation by Dorry Segev, Johns Hopkins University, Baltimore, USA – Every transplant surgeon has had his/her share of cases that turned out less… read more.

BTS 2014 Report: Normothermic organ preservation: Back to the Future

Written by | 11 Apr 2014

From the annual meeting of the British Transplantation Society in Glasgow by Marc J. Clancy.  Since its establishment within the mainstream of clinical care, the technology of organ… read more.

Heart attack damage slashed with micro particle therapy

Written by | 27 Jan 2014

First therapy to target damage after heart attack could transform field.  After a heart attack, much of the damage to the heart muscle is caused by inflammatory cells… read more.

Tweaking MRI to track creatine may spot heart problems earlier, Penn Medicine study suggests

Written by | 24 Jan 2014

Measuring creatine levels with MRI has benefits over contrast-enhanced MRI and MRS.  A new MRI method to map creatine at higher resolutions in the heart may help clinicians… read more.

FDA Highlights: Abatacept shows efficacy for Glomerulosclerosis

Written by | 8 Jan 2014

by Bruce Sylvester – Abatacept, an FDA-approved treatment of rheumatoid arthritis could become the first targeted therapy for focal segmental glomerulosclerosis glomerulosclerosis (FSGS), a condition that usually causes… read more.

ESOT 2013: Outcomes with tacrolimus-based immunosuppression after kidney transplantation with standard or extended-criteria donor organs: the OSAKA study

Written by | 24 Oct 2013

Bernhard Banas, Regensburg, Germany – Prolonged-release tacrolimus administered once-daily provides high rates of graft survival and reduction in biopsy-confirmed acute rejection (BCAR), with a manageable tolerability profile, in patients… read more.

ESOT 2013 Report – Retransplantation of abdominal organs

Written by | 23 Oct 2013

Re-transplantation is the only option available for salvaging a failed abdominal graft. As the outcomes after primary transplantations continue to improve, even with the increasing use of extended-criteria… read more.

ESOT 2013 Report – Managing infectious complications in transplant recipients

Written by | 22 Oct 2013

Invasive microbial infections are a major cause of morbidity and mortality in organ transplantation patients. The satellite symposia sponsored by Astellas Pharma at ESOT 2013 discussed the challenge… read more.

ESOT 2013 Report – Pushing the limit in clinical science

Written by | 21 Oct 2013

by Peter Friend, Oxford, UK – The 16th ESOT Congress in Vienna 2013 was one of ESOT’s most comprehensive arrangements to date, with more than 3,500 attendees and… read more.

ESOT 2013 Report – Academic, industrial and regulatory barriers to progress in transplant immunosuppression

Written by | 21 Oct 2013

Randall Morris, San Francisco, USA – Failure to make therapeutic progress is a real challenge in the transplantation field. On the face of it, the goals set up… read more.

ESOT 2013 Report – Joint Session ESOT & IPTA: Tackling the transition

Written by | 18 Oct 2013

Richard Trompeter, London, UK; Jo Wray, London, UK; Lorraine Bell, Montreal, Canada – The transition from paediatric to adult transplantation services is a major challenge for adolescent transplant… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.